M&A isn’t just for big pharma. Mid-size companies are stepping up deal hunts

May 15, 2026 08:43 AM EDT FinancingDeals M&A isn’t just for big phar­ma. A di­verse group of mid-size com­pa­nies are step­ping up deal­mak­ing Kyle LaHucik Biotech Correspondent In what is shap­ing up to be one of the most ac­tive years for bio­phar­ma M&A on record, a dif­fer­ent-look­ing set of buy­ers is go­ing … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER